Central European Journal of Chemistry

, Volume 10, Issue 5, pp 1681–1687 | Cite as

α-Amino acid-derived 2-phenylimidazoles with potential antimycobacterial activity

  • Daniel Cvejn
  • Věra Klimešová
  • Filip Bureš
Research Article


α-Amino acid-derived 2-phenylimidazole derivatives were designed, synthesized, and further investigated as potential antimycobacterial agents. The synthesis of target imidazole derivatives involved the transformation of Cbz-protected α-amino acids (Ala, Val, Phe, Leu, iLe, and Pro) into α-diazoketones and α-bromoketones, respectively. Subsequent treatment of α-bromoketones with (4-nitro)benzamidine afforded imidazole derivatives bearing α-amino acid residue appended to the imidazole C4 and (4-nitro)phenyl ring in the position C2. Antimycobacterial activities of both series of compounds against M. tuberculosis, M. avium, and M. kansasii were screened and basic structure-activity relationships were further evaluated.


Imidazole α-Amino acid Antimycobacterial agents SAR 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    S. T. Cole, G. Riccardi, Curr. Opin. Microbiol. 14, 570 (2011)CrossRefGoogle Scholar
  2. [2]
    D.E. Griffith, T. Aksamit, B.A. Brown-Elliott, A. Catanzaro, C. Daley, F. Gordin, S.M. Holland, R. Horsburgh, G. Huitt, M.F. Iademarco, M. Iseman, K. Olivier, S. Ruoss, C.F. von Reyn, R.J. Wallace Jr., K. Winthrop, Am. J. Resp. Crit. Care, 175, 367 (2007)CrossRefGoogle Scholar
  3. [3](a)
    L. Ballel, R.A. Field, K. Duncan, R.J. Young, Antimicrob. Agents Chemother. 49, 2153 (2005)CrossRefGoogle Scholar
  4. [3](b)
    R.J. O’Brien, M. Spigelman, Clin. Chest. Med. 26, 327 (2005)CrossRefGoogle Scholar
  5. [3](c)
    M. Krátký, J. Vinšová, Chem. Listy 104, 998 (2010)Google Scholar
  6. [4](a)
    M. Biava, G.C. Porretta, G. Poce, A. De Logu, R. Meleddu, E. De Rossi, F. Manetti, M. Botta, Eur. J. Med. Chem. 44, 4734 (2009)CrossRefGoogle Scholar
  7. [4](b)
    D. Deidda, G. Lampis, R. Fioravanti, M. Biava, G.C. Porretta, S. Zanetti, R. Pompei, Antimicrob. Agents Chemother. 42, 3035 (1998)Google Scholar
  8. [5]
    A. Lilienkampf, M. Pieroni, B. Wan, Y. Wang, S.G. Franzblau, A.P. Kozikowski, J. Med. Chem. 53, 678 (2010)CrossRefGoogle Scholar
  9. [6]
    G. Navarrete-Vázquez, G.M. Molina-Salinas, Z.V. Duarte-Fajardo, J. Vargas-Villarreal, S. Estrada-Soto, F. Gonzáles-Salazar, E. Hernández-Núñez, S. Said-Fernández, Bioorg. Med. Chem. 15, 5502 (2007)CrossRefGoogle Scholar
  10. [7](a)
    M. Boiani, M. González, Mini-Rev. Med. Chem. 5, 409 (2005)CrossRefGoogle Scholar
  11. [7](b)
    L. De Luca, Curr. Med. Chem. 13, 1 (2006)CrossRefGoogle Scholar
  12. [7](c)
    F. Bellina, S. Cauteruccio, R. Rossi, Tetrahedron 63, 4571 (2007)CrossRefGoogle Scholar
  13. [7](d)
    B. Dolensky, G. Nam, W.-P. Deng, J. Narayanan, J. Fan, K. L. Kirk, J. Fluorine Chem. 125, 501 (2004)CrossRefGoogle Scholar
  14. [8](a)
    C.K. Stover, P. Warrener, D.R. VanDevanter, D.R. Sherman, T.R. Arain, M.H. Langhorne, S.W. Anderson, J.A. Towell, Y. Yuan, D.N. McMurray, B.N. Kreiswirth, C.E. Barry, W.R. Baker, Nature 405, 962 (2000)CrossRefGoogle Scholar
  15. [8](b)
    M. Matsumoto, H. Hashizume, T. Tomishige, M. Kawasaki, H. Tsubouchi, H. Sasaki, Y. Shimokawa, M. Komatsu, PLoS Med. 3, 2131 (2006)CrossRefGoogle Scholar
  16. [9]
    P. Pařík, J. Jansa, S. Holešová, A. Marek, V. Klimešová, J. Heterocyclic Chem., accepted (2012)Google Scholar
  17. [10]
    O. Pytela, V. Klimešová, Chem. Pharm. Bull. 59, 179 (2011)CrossRefGoogle Scholar
  18. [11]
    W.O. Foye, T.L. Lemke, D.A. Williams, Foye’s principles of medicinal chemistry, 6th edition (Lippincott Williamsїlkins, a Wolters Kluwer, Baltimore, 2008)Google Scholar
  19. [12](a)
    F. Bureš, J. Kulhánek, Tetrahedron:Asymmetry 16, 1347 (2005)CrossRefGoogle Scholar
  20. [12](b)
    F. Bureš, T. Szotkowski, J. Kulhánek, O. Pytela, M. Ludwig, M. Holčapek, Tetrahedron: Asymmetry 17, 900 (2006)CrossRefGoogle Scholar
  21. [12](c)
    A. Marek, J. Kulhánek, M. Ludwig, F. Bureš, Molecules 12, 1183 (2007)CrossRefGoogle Scholar
  22. [12](d)
    A. Marek, J. Kulhánek, F. Bureš, Synthesis 325 (2009)Google Scholar
  23. [12](e)
    A. Marek, J. Kulhánek, W. B. Schweizer, F. Bureš, Synthesis 3188 (2010).Google Scholar
  24. [13]
    F. Bureš, PhD thesis (University of Pardubice, Pardubice, Czech Republic, 2005)Google Scholar
  25. [14]
    F.C. Schaefer, G.A. Peters, J. Org. Chem. 26, 412 (1961)CrossRefGoogle Scholar
  26. [15]
    A.R. Katritzky, A.F. Pozharskii, Handbook of heterocyclic chemistry, 2nd edition (Elsevier Science Ltd, Oxford, 2000)Google Scholar

Copyright information

© Versita Warsaw and Springer-Verlag Wien 2012

Authors and Affiliations

  1. 1.Institute of Organic Chemistry and Technology, Faculty of Chemical TechnologyUniversity of PardubicePardubiceCzech Republic
  2. 2.Department of Inorganic and Organic Chemistry, Faculty of Pharmacy in Hradec KrálovéCharles University in PragueHradec KrálovéCzech Republic

Personalised recommendations